Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinomaClinical Cancer Research, 2018, 24 (17), pp.4282-4296. ⟨10.1158/1078-0432.CCR-17-3725⟩
Journal articles
hal-01808092v1
|
||
|
ZEB1 promotes cholangiocarcinoma progression through tumor dedifferentiation and tumor-stroma paracrine signalingHepatology, 2021, 74 (6), pp.3194-3212. ⟨10.1002/hep.32069⟩
Journal articles
hal-03334112v1
|
||
|
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinomaJournal of Experimental Medicine, 2021, 218 (10), pp.1-33. ⟨10.1084/jem.20200853⟩
Journal articles
hal-03378827v1
|